Ireland - English - HPRA (Health Products Regulatory Authority)

merial animal health limited - live pneumovirus pl21 strain - lyophilisate for suspension - unknown - avian rhinotracheitis virus vaccine - fowl - chicken - immunological - live vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

merial animal health limited - live pneumovirus, pl21 strain - lyophilisate for suspension - . - avian rhinotracheitis virus - chickens - immunological - live vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - live pneumovirus, pl21 strain - lyophilisate for oculonasal suspension/use in drinking water - . - avian rhinotracheitis virus

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

merial s.a.s, france - live pneumovirus pl21 strain - lyophilisate for suspension - 21 log10 ccid50

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

merial s.a.s, france - live pneumovirus pl21 strain - lyophilisate for suspension - 21 log10 ccid50

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - live attenuated oka/merck strain of varicella-zoster virus - powder and solvent for suspension for injection - live attenuated oka/merck strain of varicella-zoster virus 19400 pfu / 0.65 ml - zoster, live attenuated - zoster, live attenuated - zostavax is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older.

European Union - English - EMA (European Medicines Agency)

laboratorios hipra s.a - live ge- tk- double-gene-deleted bovine herpes virus type 1, strain ceddel: 106.3–107.3 ccid50 - immunologicals - cattle - for the active immunisation of cattle from three months of age against bovine herpes virus type 1 (bohv-1) to reduce the clinical signs of infectious bovine rhinotracheitis (ibr) and field virus excretion.onset of immunity: 21 days after completion of the basic vaccination scheme.duration of immunity: 6 months after completion of the basic vaccination scheme

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - live newcastle disease virus clone 30 - lyophilisate for oculonasal suspension/use in drinking water - . - newcastle disease virus / paramyxovirus - chickens, turkeys - immunological - live vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - live aroa-gene deleted escherichia coli,type o78,ec34195 - unknown - live aroa-gene deleted escherichia coli,type o78,ec34195 vaccine-microbial active 0.0 - active constituent

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - live varicella vaccine, quantity: 4000 pfu/ml; isoleucine, quantity: 0.355 mg; leucine, quantity: 0.432 mg - injection, powder for - excipient ingredients: lactose; sorbitol; mannitol; threonine; serine; proline; glycine; alanine; valine; methionine; tyrosine; phenylalanine; tryptophan; lysine hydrochloride; histidine; arginine - varilrix hsa-free is indicated for active immunisation against varicella of healthy subjects from 9 months of age. groups who would particularly benefit from vaccination include: non-immune adults, especially those in at-risk occupations such as health care workers, teachers and workers in children's day-care centres. non-immune parents of young children. non-immune household contacts, both adults and children, of immunocompromised patients with no history of the disease.